Mibsons Pharmaceutical Private Limited
About Mibsons Pharmaceutical Private Limited
Data last updated:
Mibsons Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 04 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC321756. Its GSTIN is 07AALCM2463M1Z1 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rakesh Kumar and Bharti.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 213B Flat No. 7 Ward No. 2 Mehrauli, Delhi, India – 110030.
As per the financials filed for FY 2022, the company reported a revenue of ₹7.25 Lakh, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹44,732 (net margin -6.2%) and EBITDA of -₹44,297 (EBITDA margin -6.1%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mibsons Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address213B Flat No. 7 Ward No. 2 Mehrauli, Delhi, India – 110030
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Mibsons Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mibsons Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mibsons Pharmaceutical Private Limited, buy the company report.
Financials of Mibsons Pharmaceutical Private Limited
FY 2023 filings availableMibsons Pharmaceutical Private Limited reported revenue of ₹7.25 Lakh (down 26% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over three years, including a 26% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹7.25 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹44,297 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹44,732 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.1% | ||||
| Net Profit Margin | -6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mibsons Pharmaceutical Private Limited, buy the company report.
Board of directors of Mibsons Pharmaceutical Private Limited
Mibsons Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kumar Also directs: Mibsons Healthcare Private Limited | Director | 04 Aug 2017 | 9 Years 2 Months | Current |
| Bharti | Director | 04 Aug 2017 | 9 Years 2 Months | Current |
Peer comparison
Mibsons Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cadbel Pharmaceuticals Private Limited | ₹7.3 Lakh (FY 2018) | 804.0% | Bengaluru, Karnataka, India | |||
| SP Pharmaceuticals Private Limited | ₹7.29 Lakh (FY 2024) | 7.0% | Ulhasnagar, Maharashtra, India | |||
| Falconidae Healthcare Private Limited | ₹7.27 Lakh (FY 2025) | 14.0% | Jalipaiguri, West Bengal, India | |||
| Wariox Life Science Private Limited | ₹7.25 Lakh (FY 2021) | Dehradun, Uttarakhand, India | ||||
| Mibsons Pharmaceutical Private Limitedthis company | ₹7.25 Lakh (FY 2022) | -₹44,732 | -6.2% | -26.0% | Delhi, India |
To see the full peer comparison of Mibsons Pharmaceutical Private Limited, buy the company report.
Auditor
Mibsons Pharmaceutical Private Limited is audited by BHARAT BHASKAR & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHARAT BHASKAR & CO | FY 2021 | 037006N |
Shareholding
The shareholding of Mibsons Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mibsons Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mibsons Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mibsons Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mibsons Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCM2463M1Z1 | Delhi | Active | 01 Sep 2017 |
To see the full GST registrations and return filing status of Mibsons Pharmaceutical Private Limited, buy the company report.
Recent activity
Mibsons Pharmaceutical Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Bharti was appointed as Director on 04 Aug 2017.
Frequently asked questions
Mibsons Pharmaceutical is an active private limited company based in Delhi, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 04 August 2017 (9+ years old) and is registered under CIN U74999DL2017PTC321756.
Mibsons Pharmaceutical has 2 current directors:
- Rakesh Kumar - Director
- Bharti - Director
The latest financial statements of Mibsons Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Mibsons Pharmaceutical is 07AALCM2463M1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Mibsons Pharmaceutical is U74999DL2017PTC321756. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mibsons Pharmaceutical was incorporated on 04 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mibsons Pharmaceutical by revenue are Cadbel Pharmaceuticals Private Limited, SP Pharmaceuticals Private Limited, Falconidae Healthcare Private Limited, Wariox Life Science Private Limited, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Bharti was appointed as Director on 04 Aug 2017. Rakesh Kumar was appointed as Director on 04 Aug 2017.
The registered office of Mibsons Pharmaceutical is at 213B Flat No. 7 Ward No. 2 Mehrauli, Delhi, India – 110030.
Mibsons Pharmaceutical operates in the chemicals and materials industry, in the chemical distribution and retail segment.
The compliance status of Mibsons Pharmaceutical is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.